Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
side effects
Biotech
Monopar spikes chemo side effect drug after phase 2/3 analysis
Monopar is moving on from a treatment for chemotherapy side effects after disappointing phase 2 data left the company empty-handed.
Max Bayer
Mar 28, 2023 11:33am
Novartis suspends dosing in phase 2b Huntington's disease trial
Aug 24, 2022 1:03pm
A fix to PI3K cancer drugs' immune toxicity?
May 4, 2022 11:00am
FDA approves Abbott's latest Amplatzer Talisman heart implant
Oct 4, 2021 9:50am
In vivo gene editing grabs the spotlight after Intellia triumph
Sep 29, 2021 3:00am
Bellus offers a scrap of analysis for chronic cough candidate
Sep 13, 2021 10:40am